Original articles \ Ischemic heart disease
Safety and efficacy of the Essential Pro paclitaxel drug-eluting balloon for the treatment of coronary in-stent restenosis
aServicio de Cardiología Intervencionista, Instituto Cardiovascular de Buenos Aires, Buenos Aires, Argentina
bDepartment of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada
REC Interv Cardiol. 2024;6:166-171
Discordance between fractional flow reserve and nonhyperemic index with a fiber-optic pressure wire. READI EPIC-14
aServicio de Cardiología, OSI Galdakao-Barrualde, Galdakao, Bizkaia, Spain
bServicio de Cardiología, Hospital San Pedro de Alcántara, Cáceres, Spain
cServicio de Cardiología, Corporación Sanitaria Parc Taulí, Sabadell, Barcelona, Spain
dServicio de Cardiología, Hospital General Universitario de Guadalajara, Guadalajara, Spain
eServicio de Cardiología, Hospital Regional Universitario Carlos Haya, Málaga, Spain
fDepartamento de Matemáticas, Universidad de León, León, Spain
gServicio de Cardiología, Hospital Clínico Universitario Virgen de la Victoria, Málaga, Spain
hServicio de Cardiología, Hospital Sanitas La Moraleja, Alcobendas, Madrid, Spain
iServicio de Cardiología, Hospital Universitario de Burgos, Burgos, Spain
jServicio de Cardiología, Hospital General Universitario de Ciudad Real, Cuidad Real, Spain
kServicio de Cardiología, Policlínica Gipuzkoa, Donostia, Bizkaia, Spain
lServicio de Cardiología, Hospital Clínico Universitario de Valladolid, Valladolid, Spain
mServicio de Cardiología, Hospital Lucus Augusti, Lugo, Spain
nServicio de Cardiología, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain
REC Interv Cardiol. 2024;6:158-165
Plaque modification and impact on the microcirculation territory after drug-coated balloon angioplasty. The PLAMI study design
aUnidad de Hemodinámica, Servicio de Cardiología, Hospital Universitari i Politecnic La Fe, Valencia, Spain
bCentro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Spain
cInterventional Cardiology, MedStar Washington Hospital Center, Washington DC, United States
REC Interv Cardiol. 2024;6:83-88
On- vs off-hours primary percutaneous coronary intervention: a single-center 5-year experience
aCardiologia, Hospital de Braga, Braga, Portugal
bMedicina Interna, Unidade de Saúde Local do Alto Minho, Hospital de Santa Luzia, Viana do Castelo, Portugal
REC Interv Cardiol. 2024;6:76-82
Angina or ischemia with no obstructed coronary arteries: a specific diagnostic and therapeutic protocol
aHospital Clínic, Instituto Clínic Cardiovascular, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
bDipartimento di Scienze Cardiovascolari e Polmonari, Università Cattolica del Sacro Cuore, Rome, Italy
cServizio di Cardiologia Interventistica, Clinica Montevergine, Mercogliano, Italy
dDipartimento di Scienze Biomediche Avanzate, Università di Napoli, Federico II, Naples, Italy
eDipartimento di Cardiologia, Azienda ospedaliero-universitaria di Ferrara, Cona, Ferrara, Italy
fInstituto de Psiquiatría, Hospital Clìnic de Barcelona, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
gServicio de Psiquiatría y Psicología Infantil y Juvenil, Institut Clínic de Neurociències, Barcelona, Spain
◊Both authors contributed equally as first authors to this work.
REC Interv Cardiol. 2024;6:67-75
Excimer laser coronary atherectomy in severely calcified lesions: time to bust the myth
Departamento de Cardiología, Hospital Universitario La Paz, Madrid, Spain
◊Lucía Cobarro and Alfonso Jurado-Román have contributed equally and share the first authorship.
REC Interv Cardiol. 2024;6:33-40
Effectiveness of the DyeVert Power XT system during percutaneous coronary interventions
aDepartment of Interventional Cardiology, Ospedale Generale Provinciale, Macerata, Italy
bDepartment of Cardiology, Ospedale Santa Maria delle Croci, Ravenna, Italy
cDepartment of Cardiology, Ospedale di Sanremo, Sanremo, Italy
REC Interv Cardiol. 2024;6:25-32
Thermodilution assessment of vasoreactivity and microvascular function in the absence of obstructive coronary artery disease
Servicio de Cardiología, Hospital Universitario La Ribera, Alzira, Valencia, Spain
REC Interv Cardiol. 2023;5:270-278
Design of the ROLLERCOASTR trial: rotational atherectomy, lithotripsy or laser for the management of calcified coronary stenosis
aServicio de Cardiología, Hospital Universitario La Paz, Madrid, Spain
bServicio de Cardiología, Hospital Universitario Juan Ramón Jiménez, Huelva, Spain
cCentro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Spain
dServicio de Cardiología, Hospital Clínico Universitario, Valladolid, Spain
eServicio de Cardiología, Hospital Universitario San Cecilio, Granada, Spain
fServicio de Cardiología, Hospital Universitario Reina Sofía, Córdoba, Spain
gServicio de Cardiología, Hospital Universitario Lucus Augusti, Lugo, Spain
REC Interv Cardiol. 2023;5:279-286